• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前罕见和复杂结缔组织病登记系统概述以及TogethERN ReCONNET的未来前景。

An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNET.

作者信息

Bandeira Matilde, Di Cianni Federica, Marinello Diana, Arnaud Laurent, Cannizzo Sara, Carta Claudio, Cornet Alain, Barril Sara M, Bulina Inita, Ferraris Alessandro, Fonseca João, Gaglioti Andrea, Limper Marteen, Lorenzoni Valentina, Majnik Judith, Matucci-Cerinic Marco, Palla Ilaria, Rednic Simona, Schneider Matthias, Smith Vanessa, Sulli Alberto, Søndergaard Klaus, Ticciati Simone, Tincani Angela, Turchetti Giuseppe, Talarico Rosaria, Cutolo Maurizio, Mosca Marta, Taruscio Domenica

机构信息

Rheumatology Department, Lisbon Academic Medical Centre, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.

Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

出版信息

Front Med (Lausanne). 2022 Sep 26;9:889997. doi: 10.3389/fmed.2022.889997. eCollection 2022.

DOI:10.3389/fmed.2022.889997
PMID:36226147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9549150/
Abstract

BACKGROUND

Patient registries play a crucial role in supporting clinical practice, healthcare planning and medical research, offering a real-world picture on rare and complex connective tissue diseases (rCTDs). ERN ReCONNET launched the first European Registry Infrastructure with the aim to plan, upgrade and link registries for rCTDs, with the final goal to promote a harmonized data collection approach all over Europe for rCTDs.

METHODS

An online survey addressed to healthcare professionals and patients' representatives active in the field of rCTDs was integrated by an extensive database search in order to build a mapping of existing registries for rCTDs.

FINDINGS

A total of 140 registries were found, 38 of which include multiple diseases. No disease-specific registry was identified for relapsing polychondritis, mixed connective tissue disease and undifferentiated connective tissue disease.

DISCUSSION

This overview on the existing registries for rCTDs provides a useful starting point to identify the gaps and the strengths of registries on the coverage of rCTDs, and to develop a common data set and data collection approach for the establishment of the TogethERN ReCONNET Infrastructure.

摘要

背景

患者登记册在支持临床实践、医疗保健规划和医学研究方面发挥着关键作用,能呈现罕见和复杂结缔组织疾病(rCTD)的真实情况。ERN ReCONNET推出了首个欧洲登记基础设施,旨在规划、升级和链接rCTD登记册,最终目标是在全欧洲推广统一的rCTD数据收集方法。

方法

针对rCTD领域的医疗专业人员和患者代表开展了一项在线调查,并结合广泛的数据库搜索,以构建rCTD现有登记册的映射图。

结果

共发现140个登记册,其中38个包含多种疾病。未发现针对复发性多软骨炎、混合性结缔组织病和未分化结缔组织病的特定疾病登记册。

讨论

这份关于rCTD现有登记册的概述为识别登记册在rCTD覆盖范围方面的差距和优势,以及为建立TogethERN ReCONNET基础设施开发通用数据集和数据收集方法提供了有用的起点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/628b/9549150/f95788150f25/fmed-09-889997-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/628b/9549150/1555a7cc0a95/fmed-09-889997-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/628b/9549150/4cf19a95bda0/fmed-09-889997-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/628b/9549150/f95788150f25/fmed-09-889997-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/628b/9549150/1555a7cc0a95/fmed-09-889997-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/628b/9549150/4cf19a95bda0/fmed-09-889997-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/628b/9549150/f95788150f25/fmed-09-889997-g0003.jpg

相似文献

1
An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNET.当前罕见和复杂结缔组织病登记系统概述以及TogethERN ReCONNET的未来前景。
Front Med (Lausanne). 2022 Sep 26;9:889997. doi: 10.3389/fmed.2022.889997. eCollection 2022.
2
Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey.欧洲罕见和复杂结缔组织疾病的临床实践指南依从性、知识和意识:来自第一份 ERN ReCONNET 调查的结果。
RMD Open. 2020 Aug;6(2):0. doi: 10.1136/rmdopen-2020-001344.
3
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products.欧洲抗风湿病联盟(ERN)ReCONNET关于使用抗病毒疗法和抗SARS-CoV-2抗体产品治疗自身免疫性风湿病患者的考虑要点。
Clin Exp Rheumatol. 2023 Mar;41(3):543-553. doi: 10.55563/clinexprheumatol/jpargp. Epub 2023 Mar 14.
4
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET.COVID-19 对罕见和复杂结缔组织病的影响:ERN ReCONNET 的经验。
Nat Rev Rheumatol. 2021 Mar;17(3):177-184. doi: 10.1038/s41584-020-00565-z. Epub 2021 Jan 6.
5
Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases.霉酚酸酯在治疗罕见和复杂的风湿性结缔组织疾病中的应用。
Clin Exp Rheumatol. 2022 May;40 Suppl 134(5):32-39. doi: 10.55563/clinexprheumatol/v1e7s2. Epub 2022 Mar 11.
6
State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases.罕见及复杂结缔组织病和肌肉骨骼疾病生活质量评估的现状与未来方向
Front Med (Lausanne). 2022 Sep 23;9:986218. doi: 10.3389/fmed.2022.986218. eCollection 2022.
7
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.欧洲罕见复杂结缔组织和肌肉骨骼疾病参考网络的附加值:ERN ReCONNET 成立后的前 5 年得到的启示。
Clin Exp Rheumatol. 2022 May;40 Suppl 134(5):3-11. doi: 10.55563/clinexprheumatol/d2qz38. Epub 2022 Mar 29.
8
RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks.罕见病和复杂疾病欧洲参考网络优化患者护理路径的方法:RarERN路径
Orphanet J Rare Dis. 2020 Dec 14;15(1):347. doi: 10.1186/s13023-020-01631-1.
9
Clinical practice guidelines: the first year of activity of the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET).临床实践指南:欧洲罕见和复杂结缔组织及肌肉骨骼疾病参考网络(ERN ReCONNET)活动的第一年
RMD Open. 2018 Oct 18;4(Suppl 1):e000791. doi: 10.1136/rmdopen-2018-000791. eCollection 2018.
10
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives.不同经济分析层面下的罕见病:当前活动、挑战与展望
RMD Open. 2018 Nov 12;4(Suppl 1):e000794. doi: 10.1136/rmdopen-2018-000794. eCollection 2018.

引用本文的文献

1
A cost-of-illness study of Behçet syndrome in Italy.意大利的贝切特综合征疾病成本研究。
Eur J Health Econ. 2024 Apr;25(3):411-422. doi: 10.1007/s10198-023-01593-8. Epub 2023 May 22.
2
Myositis Multidisciplinary Clinic in a Tertiary Referral Center.三级转诊中心的肌炎多学科诊所。
J Multidiscip Healthc. 2023 Apr 26;16:1127-1139. doi: 10.2147/JMDH.S404017. eCollection 2023.

本文引用的文献

1
TuberOus SClerosis Registry to Increase Disease Awareness: A Review on Alignment of Its Planning, Execution, and Publications With European Medicines Agency Guidelines.结节性硬化症登记处提高疾病认知度:对其规划、实施及出版物与欧洲药品管理局指南一致性的综述
Front Neurol. 2020 May 15;11:365. doi: 10.3389/fneur.2020.00365. eCollection 2020.
2
The current landscape of European registries for rare endocrine conditions.欧洲罕见内分泌疾病登记处的现状。
Eur J Endocrinol. 2019 Jan 1;180(1):89-98. doi: 10.1530/EJE-18-0861.
3
Impact of clinical registries on quality of patient care and clinical outcomes: A systematic review.
临床注册登记对患者护理质量和临床结局的影响:一项系统综述。
PLoS One. 2017 Sep 8;12(9):e0183667. doi: 10.1371/journal.pone.0183667. eCollection 2017.
4
The EPIRARE proposal of a set of indicators and common data elements for the European platform for rare disease registration.欧洲罕见病登记平台的一套指标和通用数据元素的EPIRARE提案。
Arch Public Health. 2014 Oct 13;72(1):35. doi: 10.1186/2049-3258-72-35. eCollection 2014.
5
RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research.RD-Connect:一个连接数据库、登记处、生物样本库和临床生物信息学以进行罕见病研究的集成平台。
J Gen Intern Med. 2014 Aug;29 Suppl 3(Suppl 3):S780-7. doi: 10.1007/s11606-014-2908-8.